oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

APO-LOZART

Detected contamination with N-nitroso-N-methylamino butyric acid (NMBA) in some batches of the losartan potassium active substance. Potential effects: carcinogenicity, increased long-term health risk.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

App Store Google Play
APO-LOZART
Risk Level
Critical
Manufacturer
Apotex Europe B.V. z siedzibą w Holandii
Recall Date
01.02.2019
Category
Medicines & supplements
View official statement

Important Information

What You Should Know

Recommendations

Do not use products from suspected batches; check the batch number with the pharmacy or manufacturer and return the product; consult a physician if in doubt.

Actions Taken

Decision of the Chief Pharmaceutical Inspector to prohibit placing on the market and to immediately withdraw batches of the medicinal product containing the active substance originating from Hetero La...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: Detected contamination with N-nitroso-N-methylamino butyric acid (NMBA) in some batches of the losartan potassium active substance. Potential effects: carcinogenicity, increased long-term health risk.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Check the official report for specific batch details.

Related

Other Recalled Products

Lorafen

Lorafen

06.02.2026
Carmustine Accord

Carmustine Accord

03.02.2026
Taromentin

Taromentin

30.01.2026
Plerixafor MSN

Plerixafor MSN

29.01.2026
Zoledronic Acid Noridem

Zoledronic Acid Noridem

29.01.2026